#chr	start	end	ref	obs	tumor_af	tumor_dp	normal_af	normal_dp	snp_q	gene	variant_type	coding_and_splicing	interpro	Pathway(KEGG)_full	Function_description	Pathway(BioCarta)_full	RepeatMasker	dbSNP	1000g	ExAC	ESP6500EA	ESP6500AA	COSMIC	OMIM	ClinVar	HGMD	phyloP	MetaLR	Sift	PP2_HVAR	PP2_HDIV	ihdb_hom	ihdb_het	ihdb_wt	ihdb_allsys_hom	ihdb_allsys_het	classification	validated	comment	GPD_gene	GPD_var	som_ihdb_c	som_ihdb_p	filter
chr8	38271515	38271515	T	C	0.4657	604	0.0000	291	606	FGFR1,LETM2	missense_variant,downstream_gene_variant	FGFR1:NM_001174067.1:missense_variant:MODERATE:exon18/19:c.2306A>G:p.His769Arg,FGFR1:NM_001174065.1:missense_variant:MODERATE:exon17/18:c.2207A>G:p.His736Arg,FGFR1:NM_001174066.1:missense_variant:MODERATE:exon16/17:c.1946A>G:p.His649Arg,FGFR1:NM_001174063.1:missense_variant:MODERATE:exon17/18:c.2207A>G:p.His736Arg,FGFR1:NM_001174064.1:missense_variant:MODERATE:exon18/19:c.2183A>G:p.His728Arg,FGFR1:NM_015850.3:missense_variant:MODERATE:exon17/18:c.2207A>G:p.His736Arg,FGFR1:NM_023105.2:missense_variant:MODERATE:exon16/17:c.1946A>G:p.His649Arg,FGFR1:NM_023106.2:missense_variant:MODERATE:exon16/17:c.1940A>G:p.His647Arg,FGFR1:NM_023110.2:missense_variant:MODERATE:exon17/18:c.2213A>G:p.His738Arg,LETM2:NM_001286819.1:downstream_gene_variant:MODIFIER::c.*1638T>C:,LETM2:NM_001199659.2:downstream_gene_variant:MODIFIER::c.*1567T>C:,LETM2:NM_001286787.1:downstream_gene_variant:MODIFIER::c.*1553T>C:,LETM2:NM_144652.3:downstream_gene_variant:MODIFIER::c.*1423T>C:,LETM2:NM_001199660.2:downstream_gene_variant:MODIFIER::c.*1406T>C:	Serine-threonine/tyrosine-protein_kinase_(2),Protein_kinase-like_domain_(1),Tyrosine-protein_kinase,_catalytic_domain_(1),Protein_kinase,_catalytic_domain_(1),	MAPK signaling pathway;Adherens junction;Regulation of actin cytoskeleton;Prostate cancer;Melanoma	Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation				0.0000	0.0000	0.0000	0.0000		136350 [FGFR1 (confirmed) Pfeiffer syndrome|Jackson-Weiss syndrome|Hypogonadotropic hypogonadism 2 with or without anosmia|Osteoglophonic dysplasia|Trigonocephaly 1|Hartsfield syndrome];		N [CLASS=N MUT=N PHEN=N GENE=N]; 	4.896000	T	D,D,D,D,D,D,D,D,D,D,D	P,P,P,P,P	B,B,P,P,P	0.0000	0.0000	1.0000	0	0						1	GT,	PASS
chr9	98231134	98231134	C	T	0.1708	410	0.0000	374	203	PTCH1,LOC100507346	missense_variant,non_coding_exon_variant	PTCH1:NM_000264.3:missense_variant:MODERATE:exon14/24:c.2149G>A:p.Asp717Asn,PTCH1:NM_001083607.1:missense_variant:MODERATE:exon14/24:c.1696G>A:p.Asp566Asn,PTCH1:NM_001083606.1:missense_variant:MODERATE:exon14/24:c.1696G>A:p.Asp566Asn,PTCH1:NM_001083604.1:missense_variant:MODERATE:exon14/24:c.1696G>A:p.Asp566Asn,PTCH1:NM_001083605.1:missense_variant:MODERATE:exon14/24:c.1696G>A:p.Asp566Asn,PTCH1:NM_001083602.1:missense_variant:MODERATE:exon14/24:c.1951G>A:p.Asp651Asn,PTCH1:NM_001083603.1:missense_variant:MODERATE:exon14/24:c.2146G>A:p.Asp716Asn,LOC100507346:NR_038982.1:non_coding_exon_variant:MODIFIER:exon4/4:n.790C>T:		Hedgehog signaling pathway;Basal cell carcinoma	Acts as a receptor for sonic hedgehog (SHH), indian hedgehog (IHH) and desert hedgehog (DHH). Associates with the smoothened protein (SMO) to transduce the hedgehog's proteins signal. Seems to have a tumor suppressor function, as inactivation of this protein is probably a necessary, if not sufficient step for tumorigenesis	Sonic Hedgehog (Shh) Pathway;Sonic Hedgehog (SHH) Receptor Ptc1 Regulates cell cycle			0.0000	0.0000	0.0000	0.0000		601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];		N [CLASS=N MUT=N PHEN=N GENE=N]; 	7.192000	T	T,T,T,T,T,T,T,T	P,B,B,B	B,B,B,B	0.0000	0.0000	1.0000	0	0						1	GT,	PASS
chrX	48651570	48651570	G	A	0.9416	158	0.0000	137	652	GATA1	splice_region_variant&intron_variant	GATA1:NM_002049.3:splice_region_variant&intron_variant:LOW:exon4/5:c.745-9G>A:			Transcriptional activator which probably serves as a general switch factor for erythroid development. It binds to DNA sites with the consensus sequence [AT]GATA[AG] within regulatory regions of globin genes and of other genes expressed in erythroid cells	Hemoglobin's Chaperone		rs371005242	0.0000	1.647e-04	0.0001	0.0000				N [CLASS=N MUT=N PHEN=N GENE=N]; 						0.0000	0.0000	1.0000	0	0				9022		1	GT,	PASS
